Pharmacotherapy of atrial fibrillation in COVID-19 patients

The coronavirus pandemic disease 2019 (COVID-19) has changed the face of contemporary medicine. However, each and every medical practitioner must be aware of potential early and late complications of COVID-19, its impact on chronic diseases — especially ones as common as atrial fibrillation (AF) — a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomaszuk-Kazberuk, Anna, Koziński, Marek, Domienik-Karłowicz, Justyna, Jaguszewski, Miłosz, Darocha, Szymon, Wybraniec, Maciej, Dobrowolski, Piotr, Kupczyńska, Karolina, Michalski, Błażej, Wańha, Wojciech, Kapłon-Cieślicka, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428936/
https://www.ncbi.nlm.nih.gov/pubmed/34382204
http://dx.doi.org/10.5603/CJ.a2021.0088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428936/
https://www.ncbi.nlm.nih.gov/pubmed/34382204
http://dx.doi.org/10.5603/CJ.a2021.0088

Ejemplares similares